FASEB J. Cell Migration Consortium
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hahner, L.
Right arrow Articles by Harris, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hahner, L.
Right arrow Articles by Harris, R. A.

The FASEB Journal, Vol 5, 2466-2472, Copyright © 1991 by The Federation of American Societies for Experimental Biology

RESEARCH COMMUNICATIONS

Cerebellar GABAB receptors modulate function of GABAA receptors

L Hahner, S McQuilkin and RA Harris
Veterans Administration Medical Center, Denver, Colorado.

Interactions between GABAA and GABAB receptors were studied using muscimol-stimulated uptake of 36Cl- by membrane vesicles from mouse cerebellum. Baclofen inhibited muscimol-stimulated 36Cl- uptake and this action was more pronounced with longer flux times (30 vs. 3 s) and after predesensitization of GABAA receptors. Baclofen also inhibited 36Cl- flux by cortical membranes but was more effective with cerebellar preparations. The action of baclofen was stereoselective, calcium- dependent, and blocked by the GABAB receptor antagonist 2-OH-saclofen. It was mimicked by GTP-gamma-S but not by GDP-beta-S, which suggests that baclofen may be acting via a G protein. The action of baclofen was inhibited by U73122, an inhibitor of phospholipase C. However, the potassium channel blockers tetraethylammonium or Ba2+ did not affect the action of baclofen. The results show that activation of GABAB receptors can inhibit the function of GABAA receptors and suggest that this action involves either a nondesensitizing subtype of GABAA receptor or the rate or recycling of desensitized to nondesensitized receptors. We speculate that this action of baclofen results from activation of phospholipase C and phosphorylation of a subtype of GABAA receptor by protein kinase C.


This article has been cited by other articles:


Home page
 J. Neurophysiol.Home page
U. Kim and L.-y. Chung
Dual GABAergic Synaptic Response of Fast Excitation and Slow Inhibition in the Medial Habenula of Rat Epithalamus
J Neurophysiol, September 1, 2007; 98(3): 1323 - 1332.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Kiyokawa, T. Baba, N. Otsuka, A. Makino, S. Ohno, and T. Kobayashi
Spatial and Functional Heterogeneity of Sphingolipid-rich Membrane Domains
J. Biol. Chem., June 24, 2005; 280(25): 24072 - 24084.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
K. T. Blackwell
Calcium Waves and Closure of Potassium Channels in Response to GABA Stimulation in Hermissenda Type B Photoreceptors
J Neurophysiol, February 1, 2002; 87(2): 776 - 792.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
D. Mouginot, S. B. Kombian, and Q. J. Pittman
Activation of Presynaptic GABAB Receptors Inhibits Evoked IPSCs in Rat Magnocellular Neurons In Vitro
J Neurophysiol, March 1, 1998; 79(3): 1508 - 1517.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by The Federation of American Societies for Experimental Biology.